File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Prevention of hypoglycaemia in a patient with pancreatic microadenomatosis by a long-acting somatostatin analogue SMS 201-995

TitlePrevention of hypoglycaemia in a patient with pancreatic microadenomatosis by a long-acting somatostatin analogue SMS 201-995
Authors
Issue Date1987
PublisherWiley-Blackwell Publishing Ltd.. The Journal's web site is located at http://www.wiley.com/bw/journal.asp?ref=0300-0664
Citation
Clinical Endocrinology, 1987, v. 27 n. 4, p. 469-473 How to Cite?
AbstractAcute suppression of insulin secretion from pancreatic insulinomas by long-acting somatostatin analogue SMS 201-995 has been documented. We report the chronic use of the drug in a patient with persistent hypoglycaemia due to benign microadenomatosis with satisfactory control of plasma glucose level and reduction of insulin production. There was no tachyphylaxis or untoward side-effect noted during the 6-month treatment period.
Persistent Identifierhttp://hdl.handle.net/10722/161727
ISSN
2015 Impact Factor: 3.487
2015 SCImago Journal Rankings: 1.314
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorKung, AWCen_US
dc.contributor.authorMa, JTCen_US
dc.contributor.authorWang, Cen_US
dc.contributor.authorFu, KHen_US
dc.contributor.authorLam, KSLen_US
dc.contributor.authorYeung, RTTen_US
dc.contributor.authorBoey, Jen_US
dc.date.accessioned2012-09-05T05:14:22Z-
dc.date.available2012-09-05T05:14:22Z-
dc.date.issued1987en_US
dc.identifier.citationClinical Endocrinology, 1987, v. 27 n. 4, p. 469-473en_US
dc.identifier.issn0300-0664en_US
dc.identifier.urihttp://hdl.handle.net/10722/161727-
dc.description.abstractAcute suppression of insulin secretion from pancreatic insulinomas by long-acting somatostatin analogue SMS 201-995 has been documented. We report the chronic use of the drug in a patient with persistent hypoglycaemia due to benign microadenomatosis with satisfactory control of plasma glucose level and reduction of insulin production. There was no tachyphylaxis or untoward side-effect noted during the 6-month treatment period.en_US
dc.languageengen_US
dc.publisherWiley-Blackwell Publishing Ltd.. The Journal's web site is located at http://www.wiley.com/bw/journal.asp?ref=0300-0664en_US
dc.relation.ispartofClinical Endocrinologyen_US
dc.subject.meshAdenoma - Complications - Secretion - Surgeryen_US
dc.subject.meshFemaleen_US
dc.subject.meshHumansen_US
dc.subject.meshHypoglycemia - Drug Therapy - Etiologyen_US
dc.subject.meshInsulin - Secretionen_US
dc.subject.meshMiddle Ageden_US
dc.subject.meshOctreotideen_US
dc.subject.meshPancreatectomyen_US
dc.subject.meshPancreatic Neoplasms - Complications - Secretion - Surgeryen_US
dc.subject.meshSomatostatin - Analogs & Derivatives - Therapeutic Useen_US
dc.titlePrevention of hypoglycaemia in a patient with pancreatic microadenomatosis by a long-acting somatostatin analogue SMS 201-995en_US
dc.typeArticleen_US
dc.identifier.emailKung, AWC:awckung@hku.hken_US
dc.identifier.emailLam, KSL:ksllam@hku.hken_US
dc.identifier.authorityKung, AWC=rp00368en_US
dc.identifier.authorityLam, KSL=rp00343en_US
dc.description.naturelink_to_subscribed_fulltexten_US
dc.identifier.doi10.1111/j.1365-2265.1987.tb01175.x-
dc.identifier.pmid2893673-
dc.identifier.scopuseid_2-s2.0-0023231793en_US
dc.identifier.volume27en_US
dc.identifier.issue4en_US
dc.identifier.spage469en_US
dc.identifier.epage473en_US
dc.identifier.isiWOS:A1987K192700009-
dc.publisher.placeUnited Kingdomen_US
dc.identifier.scopusauthoridKung, AWC=7102322339en_US
dc.identifier.scopusauthoridMa, JTC=24491943700en_US
dc.identifier.scopusauthoridWang, C=7501631357en_US
dc.identifier.scopusauthoridFu, KH=36902086200en_US
dc.identifier.scopusauthoridLam, KSL=8082870600en_US
dc.identifier.scopusauthoridYeung, RTT=7102833337en_US
dc.identifier.scopusauthoridBoey, J=7003838670en_US

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats